Please provide your email address to receive an email when new articles are posted on . Bonds have a coupon rate, which is the interest an issuer pays you for loaning them money. Bonds have a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Radiologists ...

Takeda’s $300 million bet on Protagonist Therapeutics’ hematology asset a year ago appears to have paid off as the drug reduced blood procedures among patients with a rare type of cancer in a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with ...

Once they’ve graduated, their education and training include: Medical school Residency in internal medicine Fellowship in hematology oncology (3 years) After completing a medical residency and a ...

1Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.

Mortality among young adults in the United States increased since 1999, driven by overdose, suicide, and homicide, with COVID-19 exacerbating the trend. Accidental poisoning and exposure to ...

Despite major changes in the prevalence of antibiotic resistance, the 2011 IDSA guideline for uncomplicated UTI still accurately reflects the efficacy and safety of first-line treatments. New data ...

Hematology oncology is a medical specialty concerned with diagnosing and treating blood, bone marrow, and lymphatic system cancers such as leukemia and lymphoma. It is sometimes also referred to as ...

"Unsurprisingly, pirtobrutinib [Jaypirca, Eli Lilly & Co.] was superior to the comparator arm in terms of progression-free survival," Woyach, professor in the division of hematology at The Ohio ...

Based on data from the Beamion LUNG-1 trial, the FDA granted a priority review to zongertinib for patients with HER2-mutant advanced non–small cell lung cancer. The FDA accepted and granted priority ...